EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics

Konstantina Athanasopoulou iD, Glykeria N Daneva, Vasiliki-Ioanna Michalopoulou iD, Maria R Stamelou, Panagiotis Tsiakanikas iD, Panagiotis G Adamopoulos iD

Current Issues in Molecular Biology · 11.08.2026 · 48 (8) · 809

DOI: 10.3390/cimb48080809 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 11.08.2026. Verfasst von Konstantina Athanasopoulou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece. Die Arbeit nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics have evolved from passive genetic intermediaries into highly programmable platforms, fundamentally transforming the landscape of precision medicine. This comprehensive review examines the molecular architecture and mechanisms of established platforms in the clinical setting, including mRNA, antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs) and aptamers, alongside next-generation platforms, such as CRISPR-guided systems and circular RNAs (circRNAs). Moreover, we discuss strategies to overcome systemic delivery bottlenecks and evaluate advanced non-viral systems, emphasizing lipid nanoparticles (LNPs), polymers and tissue-specific ligand conjugates that facilitate precise intracellular targeting. Furthermore, we explore the clinical expansion of these platforms across infectious diseases, rare genetic disorders, oncology and cardiovascular conditions. Finally, we highlight how the integration of artificial intelligence (AI) and machine learning (ML) redefines the limits of individualized, programmable RNA therapies by accelerating sequence optimization and nanoparticle formulation.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/CasRNA delivery platformsantisense oligonucleotides (ASOs)aptamerscircular RNAs (circRNAs)lipid nanoparticles (LNPs)mRNA vaccinessmall interfering RNAs (siRNAs)targeted therapy

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece.

ORCID-Profile: Konstantina Athanasopoulou, Vasiliki-Ioanna Michalopoulou, Panagiotis Tsiakanikas, Panagiotis G Adamopoulos

Zitieren

APA

Athanasopoulou, K., Daneva, G. N., Michalopoulou, V. I., Stamelou, M. R., Tsiakanikas, P., & Adamopoulos, P. G. (2026). Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics. Current Issues in Molecular Biology, 48(8), 809. https://doi.org/10.3390/cimb48080809

Vancouver

Athanasopoulou K, Daneva GN, Michalopoulou VI, Stamelou MR, Tsiakanikas P, Adamopoulos PG. Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics. Current Issues in Molecular Biology. 2026;48(8):809. doi:10.3390/cimb48080809

BibTeX
@article{Athanasopoulou2026,
  author = {Athanasopoulou, Konstantina and Daneva, Glykeria N and Michalopoulou, Vasiliki-Ioanna and Stamelou, Maria R and Tsiakanikas, Panagiotis and Adamopoulos, Panagiotis G},
  title = {Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {8},
  pages = {809},
  doi = {10.3390/cimb48080809}
}
Kostenlos starten →